Presentation Information
[O-15-1]The CGRP Monoclonal Antibody Treatment Affects Brain Volume and Magnetic Susceptibility in Migraine
Yuya Kano1,2, Yuto Uchida2,3, Hirohito Kan4, Keita Sakurai5, Haruto Shibata2,6, Mitsuharu Yamamoto7, Koji Takada1, Takao Takeshima8, Noriyuki Matsukawa2 (1.Department of Neurology, Toyokawa City Hospital, Japan, 2.Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Japan, 3.Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, USA, 4.Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan, 5.Department of Radiology, National Center for Geriatrics and Gerontology, Japan, 6.Department of Neurology, Nagoya City University East Medical Center, Japan, 7.Department of Neurosurgery, Toyokawa City Hospital, Japan, 8.Department of Neurology, Tominaga Hospital, Japan)